SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.170+2.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich H who wrote (435)11/4/2000 2:34:27 PM
From: Kramer   of 441
 
re/finally the range/ I would have agreed with your deserves ~$9 maybe a year ago, but now neog has grown much stronger, evidenced by their last quarter results, which also reflects their acquisitions, new products and new products ready to come out of the pipeline. I am setting my deserves target at $14 to $18. if we continue to get numbers like last quarters revenues and improve the profitability, especially for acumedia, and finally get the gmo product out, I will raise my target to the $20s.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext